TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG Trademark Information

GENENTECH, INC.

Pharmaceutical oncology preparations

Perfect for these industries

Words that describe this mark

pharmaceutical   oncology   preparations  

This is a brand page for the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark by GENENTECH, INC.  in SOUTH SAN FRANCISCO, CA, 940804990.

Write a review about a product or service associated with this TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark. Or, contact the owner GENENTECH, INC. of the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark.

On Wednesday, December 16, 2015, a U.S. federal trademark registration was filed for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG by GENENTECH, INC., SOUTH SAN FRANCISCO, CA 940804990. The USPTO has given the TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark serial number of 86850524. The current federal status of this trademark filing is ABANDONED - EXPRESS. The correspondent listed for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is GENENTECH, INC. of 1 DNA WAY, SOUTH SAN FRANCISCO, CA 94080-4990, . The TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG is Pharmaceutical oncology preparations.

Word mark: TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Status/Status Date:
ABANDONED - EXPRESS
9/22/2016
Serial Number: 86850524
Filing Date: 12/16/2015
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical oncology preparations
Mark Description: The mark consists of THE WORD TECENTRIQ WITH ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG UNDER IT. THE FIRST T IN TECENTRIQ HAS THREE ARROWS POINTING INWARDS IN A CIRCLE ABOVE IT IN THE UPPER LEFT HAND CORNER.
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner: GENENTECH, INC.
SOUTH SAN FRANCISCO, CA 940804990
Mark Drawing Code: Drawing/Design + Words
Design Search:
Arrowheads (Heraldry, flags, crowns, crosses, arrows and symbols - Arrows) see more design...
More than one arrow (Heraldry, flags, crowns, crosses, arrows and symbols - Arrows) see more design...
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080-4990

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. LegalForce - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
Free Trademark Search
Current Trademark Status:
9/22/2016
ABANDONED - EXPRESS
Correspondent Search:

GENENTECH, INC. is a correspondent of TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!